Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a

Experimental and Clinical Immunogenetics

Volumn 18, Issue 2, 2001, Pages 86-95

  Brockdorff, Johannes Lundin ^a   Gu, Haihua ^a   Mustelin, Tomas ^b   Kaltoft, Keld ^d   Geisler, Carsten ^a   Röpke, Carsten ^d   Ødum, Niels ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NONE

Author keywords

Gab2; Interleukin 2; Mycosis fungoides; SHP2; Stat5; T cells

Indexed keywords

ADAPTOR PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PROTEIN GAB2; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; STAT5 PROTEIN; STAT5A PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR CELL CULTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BINDING SITES; DNA-BINDING PROTEINS; ENZYME INDUCTION; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MILK PROTEINS; MYCOSIS FUNGOIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; SHP1 PROTEIN TYROSINE PHOSPHATASE; SKIN NEOPLASMS; SRC-FAMILY KINASES; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0035021881     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049187     Document Type: Article

References (37)

1. Weinstock MA, Horm JW: Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA 1998;260:42-46.
2. Nasu K, Said J, Vonderhcid E, Olerud J, Sako D, Kadin M: Immunopathology of cutaneous T-cell lymphomas. Am J Pathol. 1985;119: 436-447.
3. Waldmann TA: T-cell receptors for cytokines: Targets for immunotherapy of leukemia/lymphoma. Ann Oncol 2000;11(suppl 1):101-106.
4. Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA: Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sćzary syndrome. Proc Natl Acad Sci USA 1996;93: 9148-9153.
5. Stefanato CM, Tallini G, Crotty PL: Histologic and immunophenotypic features prior to transformation in patients with transformed cutaneous T-cell lymphoma: Is CD25 expression in skin biopsy samples predictive of large cell transformation in cutaneous T-cell lymphoma? Am J Dermatopathol 1998;20:1-6.
6. Lin JX, Leonard WJ: Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev 1997;8: 313-332.
7. Leonard WJ, Kronke M, Peffer NJ, Depper JM, Greene WC: Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci USA 1985;82:6281-6285.
8. Hansen ER: Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma. Arch Dermatol 1996;132:554-561.
9. Samuelson E: Cutaneous T-cell lymphomas. Semin Oncol Nurs 1998; 14:293-301.
10. Kaltoft K, Hansen BH, Thestrup-Pedersen K: Cytogenetic findings in cell lines from cutaneous T-cell lymphoma. Dermatol Clin 1994;12: 295-304.
11. Asadullah K, Docke WD, Volk HD, Slerry W: Cytokines and cutaneous T-cell lymphomas. Exp Dermatol 1998;7:314-320.
12. Yu CL, Jove R, Burakoff SJ: Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J Immunol 1997;159: 5206-5210.
13. Nielsen M, Kaltoft K, Nordahl M, Ropke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N: Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci USA 1997;94: 6764-6769.
14. Gesbert F, Delespine-Carmagnat M, Bertoglio J: Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol 1998;18:307-320.
15. Karnitz LM, Abraham RT: Interleukin-2 receptor signaling mechanisms. Adv Immunol 1996;61:147-199.
16. Nielsen M, Svejgaard A, Skov S, Odum N: Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol 1994; 24:3082-3086.
17. Brockdorff J, Nielsen M, Kaltoft K, Mustelin T, Röpke C, Svejgaard A, Geisler C, Odum N: Lck is involved in IL-2-induced proliferation, but not cell survival, in human T cells through a MAP kinase-independent pathway. Eur Cytokine Netw 2000; 11:225-231.
18. Brockdorff J, Kanner SB, Nielsen M, Borregaard N, Geisler C, Svejgaard A, Odum N: Interleukin-2 induces beta-2-integrin-dependent signal transduction involving the focal adhesion kinase-related protein B (fakB). Proc Natl Acad Sci USA 1998;95:6959-6964.
19. Neel BG: Role of phosphatases in lymphocyte activation. Curr Opin Immunol 1997;9:405-420.
20. Mustelin T, Brockdorff J, Rudbeck L, Gjorloff-Wingren A, Han S, Wang X, Tailor P, Saxena M: The next wave: Protein tyrosine phosphatases enter T cell antigen receptor signalling. Cell Signal 1999;11: 637-650.
21. Yu CL, Jin YJ, Burakoff SJ: Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem 2000;275:599-604.
22. Gadina M, Stancalo LM, Bacon CM, Larner AC, O'Shca JJ: Involvement of SHP-2 in multiple aspects of IL-2 signaling: Evidence for a positive regulatory role. J Immunol 1998;160:4657-4661.
23. Migone TS, Cacalano NA, Taylor N, Yi T. Waldmann TA. Johnston JA: Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor, loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc Natl Acad Sci USA 1998;95:3845-3850.
24. Brockdorff J, Nielsen M, Dobson P, Geisler C, Ropke C, Svejgaard A, Odum N: Interleukin 2 induces a transient downregulation of protein phosphatase 1 and 2A activity in human T cells. Tissue Antigens 1997; 49:228-235.
25. Woetmann A, Nielsen M, Christensen ST, Brockdorff J, Kaltoft K, Engel AM, Skov S, Brender C, Geisler C, Svejgaard A, Rygaard J, Lcick V, Odum N: Inhibition of protein phosphatase 2A induces serine/ threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci USA 1999;96:10620-10625.
26. Gu H, Griffin JD, Neel BG: Characterization of two SHP-2-associated binding proteins and potential substrates in hematopoictic cells. J Biol Chem 1997;272:16421-16430.
27. Gadina M, Sudarshan C, O'Shea JJ: IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3′-kinase, and Grb2. J Immunol 1999; 162:2081-2086.
28. Gesbert F, Guenzi C, Bertoglio J: A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes. J Biol Chem 1998;273: 18273-18281.
29. Gu H, Pratt JC, Burakoff SJ, Neel BG: Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell 1998;2:729-740.
30. Nishida K, Yoshida Y, Itoh M, Fukada T, Ohtani T, Shirogane T, Atsumi T, Takahashi-Tezuka M, Ishihara K, Hibi M, Hirano T: Gabfamily adapter proteins act down-stream of cytokine and growth fac-tor receptors and T-and B-cell antigen receptors. Blood 1999;93:1809-1816.
31. Wickrema A, Uddin S, Sharma A, Chen F, Alsaycd Y, Ahmad S, Sawyer ST, Krystal G, Yi T, Nishada K, Hibi M, Hirano T, Platanias LC: Engagement of gab1 and gab2 in erythropoietin signaling. J Biol Chem 1999;274:24469-24474.
32. Gadina M, Sudarshan C, Visconti R, Zhou Y-J, Gu H, Neel BG, O'Shea J: The docking molecule Gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common γ-chain-using cytokines. J Biol Chem 2000;275: 26959-26966.
33. Zhao C, Yu DH, Shen R, Feng GS: Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1. J Biol Chem 1999;274:19649-19654.
34. Kaltoft K, Bisballe S, Dyrberg T, Boel E, Rasmussen PB, Thestrup-Pedersen K: Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides. In Vitro Cell Dev Biol 1992;28A:161-167.
35. Nielsen M, Odum N, Bendtzen K, Ryder LP, Jakobsen BK, Svejgaard A: MHC class II molecules regulate growth in human T cells. Exp Clin Immunogenet 1994;11:23-32.
36. Delespine-Carmagnat M, Bouvier G, Bertoglio J: Association of STAT1. STAT3 and STATS proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain. Eur J Immunol 2000;30:59-68.
37. Gresham BH, Dale BM, Potter JW, Chang PW, Vines CM, Lowell CA, Lagenaur CF, Willman CL: Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr. J Exp Med 2000;191:515-528.